Investors who purchased Calix, Inc. securities between January 28 and April 21, 2026, are being urged to join a class action lawsuit filed by The Schall Law Firm. The litigation centers on claims that the company misled the market regarding margin stability and the procurement costs of memory components.
A class action lawsuit has been filed against Calix, Inc. in Los Angeles, alleging the company misled shareholders regarding its financial health. The litigation centers on claims that the telecommunications firm concealed how aggressive memory module purchases temporarily inflated performance, masking underlying margin pressures during early 2026.
Lundbeck has finalized randomization for the DEEp OCEAN Phase III clinical trial, a global study evaluating the investigational drug bexicaserin. The trial targets developmental and epileptic encephalopathies, a diverse group of severe childhood-onset epilepsies that currently lack comprehensive treatment options for many of the various underlying genetic syndromes.
Investors who purchased Zoetis Inc. stock between January 14, 2025, and May 6, 2026, face a July 27 deadline to join a class action lawsuit. The litigation alleges the pharmaceutical company misled shareholders regarding the performance and safety of its key veterinary products, including Librela, Apoquel, and Cytopoint.
Lundbeck has finalized patient randomization for DEEp OCEAN, a pivotal Phase III clinical trial testing the investigational molecule bexicaserin. The study targets a wide spectrum of developmental and epileptic encephalopathies, marking a significant step toward addressing a group of severe childhood-onset conditions that currently lack universal treatment options.
Eighty-five years after the American Volunteer Group first took to the skies over China, a new initiative has launched in Nanjing to locate the remains of missing pilots. The project aims to cross-reference international archives to finally identify airmen lost during the fight against fascism in World War II.
Investors who purchased Planet Fitness shares between November 6, 2025, and May 6, 2026, are being urged to join a class action lawsuit against the company. The litigation alleges that the fitness chain violated federal securities laws by issuing false and misleading statements regarding its growth and pricing strategies.
Under the backdrop of the 2026 Farnborough International Airshow, Acron Technologies officially unveiled a consolidated corporate identity. The launch marks the first public pivot for the platform, which integrates thirteen specialized aerospace and defense firms into a single, cohesive portfolio designed to streamline mission-critical technology services.
The Schall Law Firm has launched an investigation into Alibaba Group Holding Limited following allegations that the e-commerce giant illicitly misappropriated core technology from the U.S.-based artificial intelligence company Anthropic, potentially misleading shareholders regarding the integrity of its proprietary systems.
Investors who held ADMA Biologics stock between August 9, 2024, and March 25, 2026, face a critical deadline as a class action lawsuit moves forward. The DJS Law Group is currently organizing plaintiffs to address allegations that the pharmaceutical company misled the market regarding its financial practices and internal transactions.
Investors who purchased AeroVironment, Inc. shares between June 25, 2025, and March 10, 2026, face a July 27, 2026, deadline to join a class action lawsuit. The litigation targets the company for allegedly concealing the true extent of competition regarding U.S. Space Force contracts.
A national shareholder rights firm is organizing a class action against Badger Meter, Inc., alleging the company misled investors by inflating financial performance through the premature recognition of customer orders between April 2024 and April 2026.
Investors who purchased AeroVironment, Inc. stock between June 25, 2025, and March 10, 2026, face a critical deadline as the Schall Law Firm organizes a class action lawsuit. The litigation targets alleged misrepresentations regarding competitive pressures surrounding the company’s U.S. Space Force satellite communication contracts.
The BC token reached an all-time high of approximately $0.0179 on July 20, marking a 14% surge since its previous peak just three days earlier. This latest price record underscores a steady climb for the BC.GAME ecosystem asset, which has gained over 50% in value since mid-April.
German patients requiring higher daily insulin doses will soon gain access to Medtrum’s 300U tubeless patch pump. Following a debut at the DDG 2026 conference in Berlin, the device secured a dedicated product code in the national statutory health insurance directory, clearing a critical path for reimbursement and commercial distribution.
Between July 13 and July 17, 2026, Ericsson repurchased 9,595,000 of its own Class B shares, deploying nearly 945 million Swedish kronor. The aggressive buying spree, executed via Goldman Sachs Bank Europe SE on Nasdaq Stockholm, marks a significant step in the company's 15 billion kronor capital return program.
South Korean manufacturer Shinsung Materials has secured a patent for the purification and stabilization of Ecamsule, a high-performance UV-A filter. By refining Terephthalylidene Dicamphor Sulfonic Acid into a high-purity powder, the company is addressing long-standing formulation challenges that previously hindered the ingredient's broader use in global sun care products.
Between July 13 and July 17, 2026, Ericsson repurchased 9,595,000 of its own Class B shares, committing a total of 944.88 million SEK to the effort. The acquisitions, executed on Nasdaq Stockholm by Goldman Sachs Bank Europe SE, mark a significant acceleration in the company’s ongoing capital allocation strategy.
Investors who held Regeneron Pharmaceuticals stock between August 1, 2025, and May 15, 2026, are being urged to join a class action lawsuit following claims that the company misled the market regarding the efficacy of its Phase III Fianlimab-Libtayo study.
Antengene Corporation will showcase new clinical findings for its lead oncology candidates during the European Society for Medical Oncology Annual Congress in Madrid this October. The presentations cover Phase 2 results for a Claudin 18.2 antibody-drug conjugate and updated data on a small-molecule inhibitor for resistant melanoma.
Trading million-dollar missiles against thousand-dollar drones is a losing economic strategy for modern militaries. At the Farnborough International Airshow, X-Bow Systems revealed Buckler, a supersonic interceptor priced under $100,000, designed specifically to break the current cycle of unsustainable costs in defense against Group 3 aerial threats.
Aeromexico has committed to integrating Honeywell Aerospace’s Surface Alerts (SURF-A) technology across its Boeing 737 NG and 737 MAX fleet. By deploying this system on more than 100 aircraft, the carrier aims to provide flight crews with critical automated warnings to prevent potential collisions during taxi, takeoff, and landing operations.
Zurich-based Squirro is launching a catalog of 13 pre-built AI agents designed to break the cycle of starting from scratch with every new implementation. By establishing a shared foundation for security, compliance, and system connectivity, the platform allows companies to reuse infrastructure, significantly accelerating the path from proof-of-concept to production.
The DJS Law Group has launched an investigation into Alibaba Group Holding Limited following allegations that the company improperly accessed proprietary artificial intelligence technology. The probe centers on whether Alibaba misled shareholders by failing to disclose critical information regarding these potential securities law violations.
Investors who purchased Regeneron Pharmaceuticals shares between August 1, 2025, and May 15, 2026, are being urged to join a class action lawsuit. The Schall Law Firm alleges the company misled the market regarding the potential success of its Phase III Fianlimab-Libtayo study, resulting in significant financial losses for shareholders.
Investors who purchased Planet Fitness stock between November 6, 2025, and May 6, 2026, are being urged to join a class action lawsuit filed by The Schall Law Firm. The litigation alleges the fitness chain misled shareholders regarding its growth trajectory and the efficacy of its national pricing strategies.
A digital tool capable of condensing hours of trademark research into minutes has earned top honors, as Clarivate’s RiskMark took home the 2026 CODiE Award for Best AI Tool for Lawyers. The platform leverages predictive and generative technology to navigate the mounting complexity of global intellectual property landscapes.
As global demand for artificial intelligence and hyperscale computing drives massive capital investment, Aon has expanded its Data Center Lifecycle Insurance Program to $5 billion. The upgrade aims to provide developers with deeper risk intelligence and broader coverage across the entire lifespan of complex digital infrastructure projects.
Hypershell has officially brought its X Series consumer exoskeletons to the European market, introducing a lineup powered by proprietary AI motion control. Verified by TÜV Rheinland for its end-to-end AI capabilities, the gear is designed to provide real-time, intuitive support for hikers, outdoor professionals, and rescue teams alike.
In a deal marking the largest equipment procurement in its history, Honeywell Aerospace will supply avionics and power systems for IndiGo’s massive expansion of 810 new Airbus A320neo family aircraft. The agreement deepens a decade-long partnership aimed at bolstering the Indian carrier's safety and operational efficiency as it scales globally.
